Thrombus Formation during Percutaneous Closure of an Atrial Septal Defect with an Amplatzer Septal Occluder

Yorgun H., CANPOLAT U., Kaya E. B., Aytemir K., Oto A.

TEXAS HEART INSTITUTE JOURNAL, cilt.38, sa.4, ss.427-430, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 38 Sayı: 4
  • Basım Tarihi: 2011
  • Dergi Adı: TEXAS HEART INSTITUTE JOURNAL
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.427-430
  • Anahtar Kelimeler: Anticoagulants/therapeutic use, blood coagulation/drug effects, echocardiography, transesophageal, heart catheterization/adverse effects, heart septal defects, atrial/blood/therapy, heparin/therapeutic use, prosthesis implantation/adverse effects/instrumentation, septal occluder device, thrombosis/drug therapy/etiology/prevention & control/ultrasonography, treatment outcome, PATENT FORAMEN OVALE, TRANSCATHETER CLOSURE, PLATELET, DEVICE, ACTIVATION
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Percutaneous closure of an ostium secundum-type atrial septal defect is typically a safe and effective therapeutic option in the presence of significant shunting or paradoxical embolism. Infrequently, however, periprocedural sequelae occur.